06:26:11 EST Fri 03 Feb 2023
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Vitalhub Corp (2)
Symbol VHI
Shares Issued 37,274,416
Close 2022-04-19 C$ 3.03
Recent Sedar Documents

Vitalhub licenses Synopsis to Royal Orthopaedic

2022-04-19 09:47 ET - News Release

Mr. Dan Matlow reports

VITALHUB ANNOUNCES MULTI-YEAR LICENSING DEAL OF PRE-OP SOLUTIONS, SYNOPSIS HOME AND SYNOPSIS IQ, TO THE ROYAL ORTHOPAEDIC HOSPITAL NHS TRUST

Vitalhub Corp. has signed a multiyear licensing agreement for subsidiary Intouch with Health's digital, at-home preop solutions, Synopsis Home and Synopsis iQ, to the Royal Orthopaedic Hospital NHS Foundation Trust.

The Royal Orthopaedic Hospital NHS Foundation Trust is a new customer of the company, having signed a multiyear licensing agreement to access the company's award-winning Synopsis Home and Synopsis iQ products. This sale comes as the result of the trust seeking out new solutions for managing elective care backlog, which has presented a continuing operational challenge.

The Royal Orthopaedic Hospital NHS Trust in Birmingham is an internationally renowned centre for the treatment of bone and joint disorders and the care of children with orthopedic problems and one of the largest orthopedic centres in Europe. The trust offers planned specialist care for all orthopedic subspecialties and a range of orthopedic services, from routine arthroplasty to complex spinal and oncological work. The Royal Orthopaedic Hospital NHS Trust aims to provide world-class clinical services and a clean, safe environment for its patients, visitors and staff, in addition to leading-edge research, innovation and education.

The Royal Orthopaedic Hospital NHS Trust has completed a licensing agreement for an unlimited number of preop assessments across its facility. With the integration of Synopsis Home and Synopsis iQ, the trust can expect to see better visibility into its elective backlog, streamlined preop assessments (which will alleviate managerial pressures), a triaging platform that will limit unnecessary appointments and better tend to complex patients, open integration into existing systems, flexible workflow, comprehensive and accurate preop assessments, and decision-making support that highlights risk through the 250-plus algorithms programmed into Synopsis modules. In turn, the company expects the deployment of the Synopsis solutions to empower the trust to better manage its elective backlog pressures.

"We are excited to engage in this new partnership with Royal Orthopaedic Hospital NHS Trust," said Dan Matlow, chief executive officer of Vitalhub. "This deal provides further evidence of the market traction of our award-winning Synopsis products and the ongoing demand for our offerings. We look forward to continuing to support our customers as we advance our growth strategy."

About Vitalhub Inc.

Vitalhub provides technology to health and human services providers, including hospitals, regional health authorities, mental health, long-term care, home health, and community and social services. Vitalhub solutions span the categories of electronic health record (EHR), case management, care co-ordination and optimization, and patient flow and operational visibility solutions.

The company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A (merger and acquisition) plan. Currently, Vitalhub serves more than 400 clients across Canada, the United States, the United Kingdom, Australia, the Middle East and Europe.

Vitalhub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Vitalhub team comprises more than 200 team members globally. The company is publicly traded on the Toronto Stock Exchange under the symbol VHI.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.